GOP Lawmakers Rip FDA's Generic-Drug Labeling Overhaul
In a lengthy letter, GOP lawmakers asserted that the FDA's proposed rule runs contrary to the Hatch-Waxman Act’s so-called sameness requirement, which dictates that generic and brand-name drugs share identical labels.
Regulators have argued that the inability of generics makers to unilaterally revise labeling reduces their...
Already a subscriber? Click here to login